SCHEMBL6002448

SCHEMBL6002448

[CH2]Cc1occ2ccccc12

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.35
HSD17B10 Q99714 3/20 0.35
CYP2A6 P11509 1/20 0.35
TSHR P16473 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
HPRT1 P00492 1/20 0.32
HTR2A P28223 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
KDM4E B2RXH2 2/20 0.30
HPGD P15428 2/20 0.30
GAA P10253 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
HIF1A Q16665 1/20 0.30
CYP1B1 Q16678 1/20 0.30
CYP1A2 P05177 1/20 0.30
THRB P10828 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6591672 0.83 ALDH1A1 (0.32) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL6002752 0.80 MAPT (0.30) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL2090532 0.79 MAPT (0.33) ALDH1A1TDP1HPGD
SCHEMBL6000686 0.79 DAO (0.30)
SCHEMBL28268580 0.78 ALDH1A1 (0.35) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL9739681 0.78 HTR2A (0.43) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL1746782 0.78 MAOB (0.40) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL9935525 0.78 TDP1 (0.35) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL2094693 0.78 CYP2A6 (0.35) ALDH1A1HSD17B10CYP2A6TSHRTDP1
SCHEMBL2088776 0.77 MAPT (0.35) ALDH1A1TDP1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed
EP-0247381-B1 5-FLUROROURACIL DERIVATIVES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1993-08-04 EP disclosed
US-5047521-A Anticarcinogenic agents OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-09-10 US disclosed
EP-0247381-A2 5-flurorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1987-12-02 EP disclosed